Product NDC: | 0173-0783 |
Proprietary Name: | LOVAZA |
Non Proprietary Name: | omega-3-acid ethyl esters |
Active Ingredient(s): | 900 mg/1 & nbsp; omega-3-acid ethyl esters |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0783 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021654 |
Marketing Category: | NDA |
Start Marketing Date: | 20081021 |
Package NDC: | 0173-0783-62 |
Package Description: | 4 CAPSULE, LIQUID FILLED in 1 BOTTLE (0173-0783-62) |
NDC Code | 0173-0783-62 |
Proprietary Name | LOVAZA |
Package Description | 4 CAPSULE, LIQUID FILLED in 1 BOTTLE (0173-0783-62) |
Product NDC | 0173-0783 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | omega-3-acid ethyl esters |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20081021 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | OMEGA-3-ACID ETHYL ESTERS |
Strength Number | 900 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Fatty Acids, Omega-3 [Chemical/Ingredient],Omega-3 Fatty Acid [EPC] |